Pharmacokinetic Study of Isoniazid and Rifampicin in Healthy Korean Volunteers.
Man Pyo Chung, Ho Cheol Kim, Gee Young Suh, Jeong Woong Park, Ho Joong Kim, O Jung Kwon, Chong H Rhee, Yong Choi Han, Hyo Jung Park, Myoung Min Kim, Kyung Eob Choi
Tuberc Respir Dis. 1997;44(3):479-492.   Published online 1997 Jun 1     DOI:
Citations to this article as recorded by Crossref logo
Comparison of Effectiveness and Adverse Reactions between Isoniazid 300 mg and 400 mg in Korean Patients with Pulmonary Tuberculosis
I-Nae Park, Sang-Bum Hong, Yeon-Mok Oh, Chae-Man Lim, Sang Do Lee, Younsuck Koh, Woo Sung Kim, Dong Soon Kim, Won Dong Kim, Tae Sun Shim
Tuberculosis and Respiratory Diseases.2006; 60(1): 44.     CrossRef
Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC) formulation
C.J Shishoo, S.A Shah, I.S Rathod, S.S Savale, M.J Vora
International Journal of Pharmaceutics.2001; 228(1-2): 53.     CrossRef